Obesity and Lung Disease: A Guide to Pathophysiology, Evaluation, and Management (Respiratory Medicine) 2nd edition
by Anne E. Dixon (Editor)
This new edition provides a fully updated guide to obesity’s relation to lung disease. Over forty percent of the U.S. population is obese, and obesity is increasing in much of the world. Obesity has a major impact on health conditions such as diabetes and cardiovascular disease. The effects of obesity on lung disease have drawn increasing attention in recent years. Furthermore, the COVID pandemic has dramatically illustrated how obesity affects respiratory disease, constitutes a major risk factor for COVID-19, and presents challenges to pulmonary care in the ICU.Obesity changes physiology, immune and metabolic function, and is associated with changes in diet and the microbiome, all of which combine to have a major impact on the pathogenesis of respiratory diseases. Obesity is thus a risk factor for many respiratory diseases such as asthma, pulmonary hypertension, thromboembolic disease, obstructive sleep apnea and ARDS. Obesity also complicates the management of manyother respiratory diseases and conditions such as COPD, thromboembolic disease, and the care of the critically ill patient.The objectives of this book are three-fold:
- To review how physiological, immune and metabolic factors might contribute to lung disease.
- To discuss the impact of obesity on common lung diseases
- To outline important considerations in the management of critically ill obese patients.
99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material.
